Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension

被引：0

作者：

Valentine Mismetti

Xavier Delavenne

David Montani

Souad Bezzeghoud

Olivier Delezay

Sophie Hodin

David Launay

Sylvain Marchand-Adam

Hilario Nunes

Edouard Ollier

Martine Reynaud-Gaubert

Jean Pastre

Julie Traclet

Sébastien Quetant

Sabrina Zeghmar

Laurent Bertoletti

Vincent Cottin

机构：

[1] Université Jean Monnet Saint-Étienne,Service de Pneumologie et Soins Intensifs Thoraciques, Centre de Référence de L’Hypertension Pulmonaire

[2] Mines Saint-Etienne,Service de Médecine Vasculaire et Thérapeutique

[3] INSERM,Service de Médecine Interne et d’Immunologie Clinique

[4] SAINBIOSE U1059,Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares

[5] INSERM U999 Centre de Compétence Maladies Pulmonaires Rares—OrphaLung Hôpital de Bicêtre,Centre de Compétence des Maladies Pulmonaires Rares (OrphaLung), Service de Pneumologie et Transplantation Pulmonaire

[6] INSERM,National Reference Center for Rare Pulmonary Diseases, Department of Respiratory Diseases

[7] CIC-1408,Service de Médecine Vasculaire et Thérapeutique

[8] CHU de Saint-Etienne,undefined

[9] Centre de Référence des Maladies Auto-Immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO) CHU Lille,undefined

[10] Service de Pneumologie et Explorations Fonctionnaires Respiratoires,undefined

[11] Hôpital Avicenne,undefined

[12] INSERM U1272,undefined

[13] Université Sorbonne Paris Nord,undefined

[14] CHU Nord,undefined

[15] AP-HM,undefined

[16] Aix Marseille Université,undefined

[17] Service de Pneumologie et Soins Intensifs Centre de Compétence Maladie Pulmonaire Rare (OrphaLung) Hôpital Européen Georges Pompidou,undefined

[18] AP-HP,undefined

[19] Hospices Civils de Lyon,undefined

[20] Louis Pradel Hospital,undefined

[21] Service de Pneumologie,undefined

[22] INSERM,undefined

[23] UMR1059,undefined

[24] Université Jean-Monnet,undefined

[25] INSERM,undefined

[26] CIC-1408,undefined

[27] CHU de Saint-Etienne,undefined

[28] INNOVTE,undefined

[29] Univ Lyon,undefined

[30] INRA,undefined

[31] UMR754,undefined

来源：

Respiratory Research | / 24卷

关键词：

Pulmonary hypertension; Systemic sclerosis; Proteomics analysis; Proteins; Biomarkers; Mass spectrometry;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Treatment regimens and outcome of systemic sclerosis-associated pulmonary arterial hypertension
Bjorkekjaer, Hj
Fretheim, H.
Inselseth, Hm
Midtvedt, O.
Barua, I.
Garen, T.
Bitter, H.
Andreassen, A.
Molberg, O.
Broch, K.
Hoffmann-Vold, A.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 56 - 58
[32] Treatment Regimens and Outcomes in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
Bjorkekjaer, Hilde Jenssen
Fretheim, Havard
Inselseth, Helene Marjavara
Midtvedt, Oyvind
Barua, Imon
Garen, Torhild
Bitter, Helle
Andreassen, Arne
Molberg, Oyvind
Broch, Kaspar
Hoffmann-Vold, Anna-Maria
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1116 - 1118
[33] Survival of patients with systemic sclerosis-associated pulmonary arterial hypertension has improved in the endothelin antagonist era
Williams, M. H.
Das, C.
Handler, C. E.
Akram, M. R.
Denton, C. P.
Smith, C. J.
Black, C. M.
Coghlan, J. G.
[J]. EUROPEAN HEART JOURNAL, 2005, 26 : 113 - 113
[34] Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
Lefevre, Guillaume
Dauchet, Luc
Hachulla, Eric
Montani, David
Sobanski, Vincent
Lambert, Marc
Hatron, Pierre-Yves
Humbert, Marc
Launay, David
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (09): : 2412 - 2423
[35] Clinical Characteristics And Survival Of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Diagnosed By A Systematic Detection Program
Humbert, M. J. C.
Yaici, A.
De Groote, P.
Montani, D.
Sitbon, O.
Launay, D.
Gressin, V.
Guillevin, L.
Clerson, P.
Simonneau, G.
Hachulla, E.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[36] Better Survival in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Patients Enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Chung, Lorinda
Domsic, Robyn T.
Lingala, Bharathi
Steen, Virginia D.
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S673 - S673
[37] Epoprostenol Rescue Therapy In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension
Roos, Adrienne M.
Pasarikovski, Christopher
Kron, Amie T.
Granton, John T.
Lee, Peter
Thenganatt, John
Johnson, Sindhu R.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1099 - S1099
[38] EPOPROSTENOL RESCUE THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION AND IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
Roos, A. M.
Pasarikovski, C. R.
Kron, A.
Granton, J. T.
Lee, P.
Thenganatt, J.
Johnson, S. R.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S86 - S87
[39] New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension
Mullin, Christopher J.
Mathai, Stephen C.
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (06) : 561 - 567
[40] A Systemic Review of Factors Associated with Systemic Sclerosis-associated Pulmonary Arterial Hypertension (SSc-PAH)
Jiang, Yuxuan
Turk, Matthew
Pope, Janet
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71

← 1 2 3 4 5 →